Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

The Kenya Medical Supplies Authority (KEMSA) on Friday released antiretroviral drugs (ARVs) to reach over 1 million Kenyans.

HIV commodities worth about Sh30 billion are lying at the Mombasa Road warehouses of the Mission for Essential Drugs & Supplies (MEDS), awaiting distribution, the NSDCC has said.The consignment ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...

CAGAYAN DE ORO CITY (PIA) — The Philippine Health Insurance Corporation (PhilHealth) reaffirmed its commitment to supporting ...

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

A growing number of people living with HIV are defaulting on ARV medication following the closure of specialized clinics for key populations.